5-FLUOROURACIL INCORPORATION INTO RNA OF A RAT-LIVER ADENOCARCINOMA AFTER HEPATIC-ARTERY INJECTION TOGETHER WITH DEGRADABLE STARCH MICROSPHERES

被引：5
作者：
TEDER, H
ERICHSEN, C
CHRISTENSSON, PI
JONSSON, PE
STENRAM, U
机构：
[1] LUNDS LASARETT,DEPT SURG,S-22185 LUND,SWEDEN
[2] LUNDS LASARETT,DEPT PATHOL,S-22185 LUND,SWEDEN
来源：
CANCER DRUG DELIVERY | 1987年 / 4卷 / 03期
关键词：
D O I：
10.1089/cdd.1987.4.169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：169 / 176
页数：8
相关论文
共 49 条
[31]   Effect of Metabolic Inhibitors on the Hepatic Disposition of 5-Fluorouracil after Application to the Rat Liver Surface [J].
Shimokawa, Kenta ;
Wakasugi, Kazumi ;
Tomonaga, Rei ;
Utsunomiya, Ken ;
Miyamoto, Hirotaka ;
Fumoto, Shintaro ;
Nishida, Koyo .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (03) :361-367
[32]   Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits [J].
Pohlen, U ;
Reszka, R ;
Schneider, P ;
Buhr, HJ ;
Berger, G .
ANTICANCER RESEARCH, 2004, 24 (3A) :1699-1704
[33]   EFFECT OF 5-FLUOROURACIL ON THE SYNTHESIS AND TRANSLATION OF POLYADENYLIC ACID-CONTAINING RNA FROM REGENERATING RAT-LIVER [J].
CARRICO, CK ;
GLAZER, RI .
CANCER RESEARCH, 1979, 39 (09) :3694-3701
[34]   TREATMENT OF PROBABLE SUBCLINICAL LIVER METASTASES AND GROSS PANCREATIC-CARCINOMA WITH HEPATIC-ARTERY 5-FLUOROURACIL INFUSION AND RADIATION-THERAPY [J].
WILEY, AL ;
WIRTANEN, GW ;
MEHTA, MP ;
RAMIREZ, G ;
SHAHABI, S .
ACTA ONCOLOGICA, 1988, 27 (04) :377-381
[35]   DEGRADABLE STARCH MICROSPHERES IN CYTOSTATIC TREATMENT OF A LIVER-CARCINOMA - EXPERIMENTAL STUDIES IN RATS WITH 5-FLUOROURACIL, TAUROMUSTINE, CARMUSTINE, DOXORUBICIN AND RSU-1069 [J].
ROOS, G ;
CHRISTENSSON, PI ;
ELHAG, IA ;
JAKOBSSON, B ;
TEDER, H ;
STENRAM, U .
ANTICANCER RESEARCH, 1993, 13 (03) :635-642
[36]   A PILOT-STUDY OF HEPATIC-ARTERY FLOXURIDINE COMBINED WITH SYSTEMIC 5-FLUOROURACIL AND LEUCOVORIN - A POTENTIAL ADJUVANT PROGRAM AFTER RESECTION OF COLORECTAL HEPATIC METASTASES [J].
KEMENY, N ;
CONTI, JA ;
SIGURDSON, E ;
COHEN, A ;
SEITER, K ;
LINCER, R ;
NIEDZWIECKI, D ;
BOTET, J ;
CHAPMAN, D ;
COSTA, P ;
BUDD, A .
CANCER, 1993, 71 (06) :1964-1971
[37]   Multicenter pilot study of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres Via hepatic arterial infusion in patients with nonresectable colorectal liver metastases [J].
Pohlen, U ;
Mansmann, U ;
Berger, G ;
Germer, CT ;
Gallkowski, U ;
Boese-Landgraf, J ;
Buhr, HJ .
ANTICANCER RESEARCH, 2004, 24 (5B) :3275-3282
[38]   MODULATION OF 5-FLUOROURACIL METABOLISM BY THYMIDINE - INVIVO AND INVITRO STUDIES ON RNA-DIRECTED EFFECTS IN RAT-LIVER AND HEPATOMA [J].
ENGELBRECHT, C ;
LJUNGQUIST, I ;
LEWAN, L ;
YNGNER, T .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (05) :745-750
[39]   THE EFFECT OF 5-FLUOROURACIL ON DNA-SYNTHESIS IN THE RAT-LIVER UNDERGOING COMPENSATORY HYPERPLASIA AFTER PARTIAL-HEPATECTOMY [J].
RYAN, CJ ;
WOOD, CB ;
BLUMGART, LH .
CLINICAL ONCOLOGY, 1983, 9 (01) :43-49
[40]   TREATMENT OF LIVER METASTASES FROM COLORECTAL-CANCER WITH HEPATIC-ARTERY OCCLUSION, INTRAPORTAL 5-FLUOROURACIL INFUSION, AND ORAL ALLOPURINOL - A RANDOMIZED CLINICAL-TRIAL [J].
HAFSTROM, L ;
ENGARAS, B ;
HOLMBERG, SB ;
GUSTAVSSON, B ;
JONSSON, PE ;
LINDNER, P ;
NAREDI, P ;
TIDEBRANT, G .
CANCER, 1994, 74 (10) :2749-2756
12345